Clinipace Blog

Clinipace Team Talks Innovation in Cancer Therapy at ASCO 2016

Last week, we spent time with some of the best and brightest minds in oncology at ASCO 2016 in Chicago. Speaking with so many professionals who are passionately advancing new therapies is a privilege and motivates our team to work even harder with our sponsors to develop the new treatments that are significantly improving the outcomes for patients.

read more

Understanding FDA’s Final Guidance on Exempt Infant Formula Production

Marci Ardinger is the Associate Director of Project Management at Clinipace Worldwide. Infant formulas play an important role in the overall health of infants that consume them, and the FDA has recognized that infant formulas for specific uses (i.e., infants with inborn errors of metabolism, low birth weight and other medical or dietary issues) might need

read more

Clinipace Statistical Expert Presenting at 5th Annual PhUSE and FDA Collaboration Computational Science Symposium (CSS)

Dirk Spruck, Clinipace’s Manager of Statistical Programming, will share his expertise as part of a working group during the 5th annual Computational Science Symposium (CSS) held by PhUSE and the FDA March 13 – 15, 2016 in Silver Spring, Maryland. Dirk and his collaborators, Hanming Tu of Accenture and Dante Di Tommaso of Roche, will present on behalf of

read more

Clinical Events Adjudication in the Digital Age: The CEC Process

Thank you to everyone who attended our webcast “Clinical Events Adjudication in the Digital Age.” In the presentation, we discussed when clinical events committees (CECs) are needed, CEC structures, CEC processes, what to look for when outsourcing CEC services and benefits of technology-enabled CEC processes.

read more

Clinical Events Adjudication in the Digital Age: CEC Structure

Thank you to everyone who attended our webcast “Clinical Events Adjudication in the Digital Age.” In the presentation, we discussed when clinical events committees (CECs) are needed, CEC structures, CEC processes, what to look for when outsourcing CEC services and benefits of technology-enabled CEC processes.

read more

Making Sense of Rising Oncology Drug Costs

Although cost control for drugs has been common in countries with socialized medicine or government-payer systems, this issue is now beginning to take center stage here in the United States. Despite wide coverage in the popular media, such as Dr. Ezekiel Emanuel’s editorial in The New York Times, it was quite striking to see calls for more value-based pricing at the American Society of Clinical Oncology (ASCO) meeting earlier this year.

read more

Clinipace Worldwide Honored in Inc. 500|5000 List for the Sixth Year Running

We’re having a great morning because we’ve been named to Inc. Magazine’s 34th annual Inc. 500|5000 list – for the sixth year running!
The Inc. 500|5000 list represents the most comprehensive look at America’s independent entrepreneurs. Started in 1982, this prestigious list of the nation’s most successful private companies has become the hallmark of entrepreneurial success.

read more

Clinipace’s UK Office Hosts Harding University Students

Martin Cripps is the Senior Director, Project Management, at Clinipace Worldwide. Last week, our UK office hosted a group of Harding University students and faculty as part of their summer program. This is the fourth year in a row we’ve had the pleasure of hosting this wonderful group from the university. Harding University is located in Searcy, Arkansas,

read more